Guidance A-Z — R
118 guidance documents beginning with R.
Radially emitting laser fibre treatment of an anal fistula
Radiation dose monitoring software for medical imaging with ionising radiation
Radiation therapy for early Dupuytren's disease
Radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastases
Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery
Radiofrequency ablation for colorectal liver metastases
Radiofrequency ablation for gastric antral vascular ectasia
Radiofrequency ablation for palliation of painful spinal metastases
Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma
Radiofrequency ablation of the soft palate for snoring
Radiofrequency cold ablation for respiratory papillomatosis
Radiofrequency denervation for osteoarthritic knee pain
Radiofrequency tissue reduction for turbinate hypertrophy
Radiofrequency treatment for haemorrhoids
Radiofrequency-assisted liver resection
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy
Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal)
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia
Ranibizumab for treating diabetic macular oedema
Ranibizumab for treating diabetic retinopathy (terminated appraisal)
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion
Rapid tests for group A streptococcal infections in people with a sore throat
Rare diseases
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)
Ravulizumab for treating atypical haemolytic uraemic syndrome
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)
Ravulizumab for treating paroxysmal nocturnal haemoglobinuria
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal)
Reducing sexually transmitted infections
Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues
Refractory extrapulmonary sarcoidosis: infliximab
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)
Regorafenib for previously treated advanced hepatocellular carcinoma
Regorafenib for previously treated metastatic colorectal cancer
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours
Rehabilitation after critical illness in adults
Rehabilitation after critical illness in adults
Rehabilitation after traumatic injury
Rehabilitation for adults with complex psychosis
Rehabilitation for chronic neurological disorders including acquired brain injury
Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia
Relugolix for treating hormone-sensitive prostate cancer
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids
Relugolix–estradiol–norethisterone for treating symptoms of endometriosis
Remdesivir and tixagevimab plus cilgavimab for treating COVID-19
Remote ECG interpretation consultancy services for cardiovascular disease
Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatment
Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
Renal and ureteric stones
Renal and ureteric stones: assessment and management
Renal replacement therapy and conservative management
Renal replacement therapy services for adults
RenalSense Clarity RMS for acute kidney injury
Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma
Repetitive transcranial magnetic stimulation for depression
Reslizumab for treating severe eosinophilic asthma
RespiraSense for continuously monitoring respiratory rate
Restless legs syndrome: Oxycodone/naloxone prolonged release
ReStore Soft Exo-Suit for gait rehabilitation
Retrobulbar irradiation for thyroid eye disease
Retrograde urethral sphincterometry
Reversal of the anticoagulant effect of dabigatran: idarucizumab
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia
Rheumatoid arthritis in adults: management
Rheumatoid arthritis in over 16s
Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrence
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
Rifaximin for preventing episodes of overt hepatic encephalopathy
Rimegepant for preventing migraine
Rimegepant for treating migraine
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitors
Risankizumab for previously treated moderately to severely active Crohn's disease
Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs
Risankizumab for treating moderate to severe plaque psoriasis
Risankizumab for treating moderately to severely active ulcerative colitis
Ritlecitinib for treating severe alopecia areata in people 12 years and over
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma
Rituximab for the first-line treatment of chronic lymphocytic leukaemia
Rituximab for the first-line treatment of stage III-IV follicular lymphoma
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia
Rituximab for the treatment of relapsed or refractory stage 3 or 4 follicular non-Hodgkin's lymphoma
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
Rivaroxaban for preventing venous thromboembolism after hip or knee replacement surgery
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism
Robot-assisted kidney transplant
Radiation dose monitoring software for medical imaging with ionising radiation
Radiation therapy for early Dupuytren's disease
Radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastases
Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery
Radiofrequency ablation for colorectal liver metastases
Radiofrequency ablation for gastric antral vascular ectasia
Radiofrequency ablation for palliation of painful spinal metastases
Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma
Radiofrequency ablation of the soft palate for snoring
Radiofrequency cold ablation for respiratory papillomatosis
Radiofrequency denervation for osteoarthritic knee pain
Radiofrequency tissue reduction for turbinate hypertrophy
Radiofrequency treatment for haemorrhoids
Radiofrequency-assisted liver resection
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy
Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal)
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia
Ranibizumab for treating diabetic macular oedema
Ranibizumab for treating diabetic retinopathy (terminated appraisal)
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion
Rapid tests for group A streptococcal infections in people with a sore throat
Rare diseases
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)
Ravulizumab for treating atypical haemolytic uraemic syndrome
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)
Ravulizumab for treating paroxysmal nocturnal haemoglobinuria
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal)
Reducing sexually transmitted infections
Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues
Refractory extrapulmonary sarcoidosis: infliximab
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)
Regorafenib for previously treated advanced hepatocellular carcinoma
Regorafenib for previously treated metastatic colorectal cancer
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours
Rehabilitation after critical illness in adults
Rehabilitation after critical illness in adults
Rehabilitation after traumatic injury
Rehabilitation for adults with complex psychosis
Rehabilitation for chronic neurological disorders including acquired brain injury
Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia
Relugolix for treating hormone-sensitive prostate cancer
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids
Relugolix–estradiol–norethisterone for treating symptoms of endometriosis
Remdesivir and tixagevimab plus cilgavimab for treating COVID-19
Remote ECG interpretation consultancy services for cardiovascular disease
Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatment
Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
Renal and ureteric stones
Renal and ureteric stones: assessment and management
Renal replacement therapy and conservative management
Renal replacement therapy services for adults
RenalSense Clarity RMS for acute kidney injury
Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma
Repetitive transcranial magnetic stimulation for depression
Reslizumab for treating severe eosinophilic asthma
RespiraSense for continuously monitoring respiratory rate
Restless legs syndrome: Oxycodone/naloxone prolonged release
ReStore Soft Exo-Suit for gait rehabilitation
Retrobulbar irradiation for thyroid eye disease
Retrograde urethral sphincterometry
Reversal of the anticoagulant effect of dabigatran: idarucizumab
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia
Rheumatoid arthritis in adults: management
Rheumatoid arthritis in over 16s
Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrence
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
Rifaximin for preventing episodes of overt hepatic encephalopathy
Rimegepant for preventing migraine
Rimegepant for treating migraine
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitors
Risankizumab for previously treated moderately to severely active Crohn's disease
Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs
Risankizumab for treating moderate to severe plaque psoriasis
Risankizumab for treating moderately to severely active ulcerative colitis
Ritlecitinib for treating severe alopecia areata in people 12 years and over
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma
Rituximab for the first-line treatment of chronic lymphocytic leukaemia
Rituximab for the first-line treatment of stage III-IV follicular lymphoma
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia
Rituximab for the treatment of relapsed or refractory stage 3 or 4 follicular non-Hodgkin's lymphoma
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
Rivaroxaban for preventing venous thromboembolism after hip or knee replacement surgery
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism
Robot-assisted kidney transplant
12